NCT03362619
- Conditions
- Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
- Locations
-
- Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China
Clinical trial condition
Genital Neoplasms, Female
Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.
4,641 public trials
1,049 recruiting studies
Genital Neoplasms, Female trial results
NCT03356795
- Conditions
- Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
- Locations
-
- Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China
NCT03184753
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China
NCT06315491
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- TMC Health Tucson, Arizona, United States
NCT05572684
- Conditions
- Adnexal Diseases, Advanced or Metastatic Solid Tumors, Cervical Cancer, +52 more
- Locations
-
- Arizona Oncology Associates Tucson, Arizona, United States
- Rocky Mountain Cancer Centers Aurora, Colorado, United States
- St. Elizabeth Edgewood Hospital Edgewood, Kentucky, United States
- Ochsner Cancer Institute New Orleans, Louisiana, United States
NCT05226507
- Conditions
- ARID1A Gene Mutation, Adenocarcinoma, Adnexal Diseases, +24 more
- Locations
-
- Honor Health Phoenix, Arizona, United States
- UC San Diego Health - Moores Cancer Center La Jolla, California, United States
- University of Colorado Cancer Center Aurora, Colorado, United States
- Yale Gynecologic Oncology New Haven, Connecticut, United States
NCT00799110
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Brigham & Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT05475171
- Conditions
- Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Suspended
Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors
NCT04840589
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +20 more
- Locations
-
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Mount Sinai Hospital New York, United States
- Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
NCT03987555
- Conditions
- Adnexal Diseases, Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, +58 more
- Locations
-
- Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States